The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 07, 2021
Filed:
Mar. 14, 2019
Applicant:
China Medical University, Taichung, TW;
Inventors:
Woei-Cherng Shyu, Taichung, TW;
Chen-Huan Lin, Taichung, TW;
Wei Lee, Taipei, TW;
Chia-Hung Hsieh, Taichung, TW;
Chung-Y Hsu, Taichung, TW;
Chang-Hai Tsai, Taichung, TW;
Assignee:
China Medical University, Taichung, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/28 (2015.01); C12N 5/0775 (2010.01); A61P 25/28 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 38/179 (2013.01); A61P 25/28 (2018.01); C12N 5/0665 (2013.01); C12N 5/0668 (2013.01); A61K 45/06 (2013.01); A61K 2035/124 (2013.01); C12N 2500/84 (2013.01);
Abstract
A method for treating a multiple sclerosis is provided. The method includes administering a composition containing a plurality of mesenchymal stem cells to a subject in need for a treatment of the multiple sclerosis, in which each of the mesenchymal stem cells expresses insulin-like growth factor 1 receptors.